ATP and its N⁶-substituted analogues: parameterization, molecular dynamics simulation and conformational analysis.

about

ATP and its N⁶-substituted analogues: parameterization, molecular dynamics simulation and conformational analysis.

Item

http://www.wikidata.org/entity/Q42734945

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

ATP and its N⁶-substituted ana ...... n and conformational analysis.

@en

ATP and its N⁶-substituted ana ...... n and conformational analysis.

@nl

type

Item

label

ATP and its N⁶-substituted ana ...... n and conformational analysis.

@en

ATP and its N⁶-substituted ana ...... n and conformational analysis.

@nl

prefLabel

ATP and its N⁶-substituted ana ...... n and conformational analysis.

@en

ATP and its N⁶-substituted ana ...... n and conformational analysis.

@nl

P1476

ATP and its N⁶-substituted ana ...... n and conformational analysis.

@en

P2093

Krzysztof Smalara

http://www.w3.org/2001/XMLSchema#string

Paweł Gruszczyński

http://www.w3.org/2001/XMLSchema#string

Rajmund Kaźmierkiewicz

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the interactions between the active site of a protein tyrosine kinase and a divalent metal activator.

The Amber biomolecular simulation programs

The enzymatic phosphorylation of proteins

The Cambridge Structural Database: a quarter of a million crystal structures and rising

Catalytic specificity of protein-tyrosine kinases is critical for selective signalling

Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling

Generalized born models of macromolecular solvation effects.

Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates.

Phosphorylation and ATP-binding induced conformational changes in the PrkC, Ser/Thr kinase from B. subtilis.

Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors.

P2888

s00894-010-0808-3

P304

1081-1090

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00894-010-0808-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michał Obuchowski

P577

2010-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45407268

http://www.w3.org/2001/XMLSchema#string

P698

20668896

http://www.w3.org/2001/XMLSchema#string

P932

3096017

http://www.w3.org/2001/XMLSchema#string